DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Pal SK, Puente J, Heng DYC. et al.
Phase 2 trial of lenvatinib at 2 starting doses + everolimus in renal cell carcinoma (RCC). Presented at 19th Annual Meeting of the International Kidney Cancer Symposium (IKCS 2020); November 6–7, 2020.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.